Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-07

FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for pantoprazole sodium intravenous formulation from Sandoz Inc., expanding the product to include IV administration. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole Sodium I.V. (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM I.V. (PANTOPRAZOLE SODIUM)